Historical Valuation
Conmed Corp (CNMD) is now in the Undervalued zone, suggesting that its current forward PE ratio of 9.24 is considered Undervalued compared with the five-year average of 26.22. The fair price of Conmed Corp (CNMD) is between 190.74 to 276.15 according to relative valuation methord. Compared to the current price of 44.20 USD , Conmed Corp is Undervalued By 76.83%.
Relative Value
Fair Zone
190.74-276.15
Current Price：44.20
76.83%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Conmed Corp (CNMD) has a current Price-to-Book (P/B) ratio of 1.24. Compared to its 3-year average P/B ratio of 2.89 , the current P/B ratio is approximately -57.02% higher. Relative to its 5-year average P/B ratio of 3.66, the current P/B ratio is about -66.04% higher. Conmed Corp (CNMD) has a Forward Free Cash Flow (FCF) yield of approximately 11.87%. Compared to its 3-year average FCF yield of 5.41%, the current FCF yield is approximately 119.58% lower. Relative to its 5-year average FCF yield of 4.07% , the current FCF yield is about 191.73% lower.
P/B
Median3y
2.89
Median5y
3.66
FCF Yield
Median3y
5.41
Median5y
4.07
Competitors Valuation Multiple
AI Analysis for CNMD
The average P/S ratio for CNMD competitors is 7.68, providing a benchmark for relative valuation. Conmed Corp Corp (CNMD.N) exhibits a P/S ratio of 0.90, which is -88.23% above the industry average. Given its robust revenue growth of 6.70%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for CNMD
1Y
3Y
5Y
Market capitalization of CNMD increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of CNMD in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is CNMD currently overvalued or undervalued?
Conmed Corp (CNMD) is now in the Undervalued zone, suggesting that its current forward PE ratio of 9.24 is considered Undervalued compared with the five-year average of 26.22. The fair price of Conmed Corp (CNMD) is between 190.74 to 276.15 according to relative valuation methord. Compared to the current price of 44.20 USD , Conmed Corp is Undervalued By 76.83% .
What is Conmed Corp (CNMD) fair value?
CNMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Conmed Corp (CNMD) is between 190.74 to 276.15 according to relative valuation methord.
How does CNMD's valuation metrics compare to the industry average?
The average P/S ratio for CNMD's competitors is 7.68, providing a benchmark for relative valuation. Conmed Corp Corp (CNMD) exhibits a P/S ratio of 0.90, which is -88.23% above the industry average. Given its robust revenue growth of 6.70%, this premium appears unsustainable.
What is the current P/B ratio for Conmed Corp (CNMD) as of Jan 09 2026?
As of Jan 09 2026, Conmed Corp (CNMD) has a P/B ratio of 1.24. This indicates that the market values CNMD at 1.24 times its book value.
What is the current FCF Yield for Conmed Corp (CNMD) as of Jan 09 2026?
As of Jan 09 2026, Conmed Corp (CNMD) has a FCF Yield of 11.87%. This means that for every dollar of Conmed Corp’s market capitalization, the company generates 11.87 cents in free cash flow.
What is the current Forward P/E ratio for Conmed Corp (CNMD) as of Jan 09 2026?
As of Jan 09 2026, Conmed Corp (CNMD) has a Forward P/E ratio of 9.24. This means the market is willing to pay $9.24 for every dollar of Conmed Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Conmed Corp (CNMD) as of Jan 09 2026?
As of Jan 09 2026, Conmed Corp (CNMD) has a Forward P/S ratio of 0.90. This means the market is valuing CNMD at $0.90 for every dollar of expected revenue over the next 12 months.